Literature DB >> 22232426

In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4α expression.

Anuradha Ramamoorthy1, Lang Li, Andrea Gaedigk, L DiAnne Bradford, Eric A Benson, David A Flockhart, Todd C Skaar.   

Abstract

Hepatic nuclear factor 4α (HNF4A) is a nuclear transcription factor that regulates the expression of many genes involved in drug disposition. To identify additional molecular mechanisms that regulate HNF4A, we identified microRNAs (miRNAs) that target HNF4A expression. In silico analyses suggested that HNF4A is targeted by many miRNAs. We conducted in vitro studies to validate several of these predictions. With use of an HNF4A 3'-untranslated region (UTR) luciferase reporter assay, five of six miRNAs tested significantly down-regulated (∼20-40%) the luciferase activity. In HepG2 cells, miR-34a and miR-449a also down-regulated the expression of both the HNF4A protein and an HNF4A target gene, PXR (∼30-40%). This regulation appeared without reduction in HNF4A mRNA expression, suggesting that they must be blocking HNF4A translation. Using additional bioinformatic algorithms, we identified polymorphisms that are predicted to alter the miRNA targeting of HNF4A. Luciferase assays indicated that miR-34a and miR-449a were less effective in regulating a variant (rs11574744) than the wild-type HNF4A 3'-UTR. In vivo, subjects with the variant HNF4A had lower CYP2D6 enzyme activity, although this result was not statistically significant (p = 0.16). In conclusion, our findings demonstrate strong evidence for a role of miRNAs in the regulation of HNF4A.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232426      PMCID: PMC3310421          DOI: 10.1124/dmd.111.040329

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  40 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  MicroRNA-directed cleavage of HOXB8 mRNA.

Authors:  Soraya Yekta; I-Hung Shih; David P Bartel
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

4.  Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.

Authors:  G P Hayhurst; Y H Lee; G Lambert; J M Ward; F J Gonzalez
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  LightCycler technology for the quantitation of bcr/abl fusion transcripts.

Authors:  K A Kreuzer; U Lass; A Bohn; O Landt; C A Schmidt
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

6.  The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism.

Authors:  M Stoffel; S A Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

7.  Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression.

Authors:  P Hatzis; I Talianidis
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

8.  Polymorphisms associated with circulating sex hormone levels in postmenopausal women.

Authors:  Alison M Dunning; Mitch Dowsett; Catherine S Healey; Louise Tee; Robert N Luben; Elizabeth Folkerd; Karen L Novik; Livia Kelemen; Saeko Ogata; Paul D P Pharoah; Douglas F Easton; N E Day; Bruce A J Ponder
Journal:  J Natl Cancer Inst       Date:  2004-06-16       Impact factor: 13.506

9.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

10.  Human MicroRNA targets.

Authors:  Bino John; Anton J Enright; Alexei Aravin; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  PLoS Biol       Date:  2004-10-05       Impact factor: 8.029

View more
  30 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

2.  Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223.

Authors:  Eric A Benson; Todd C Skaar
Journal:  Drug Metab Dispos       Date:  2013-07-25       Impact factor: 3.922

3.  Differentiation in stem/progenitor cells along fetal or adult hepatic stages requires transcriptional regulators independently of oscillations in microRNA expression.

Authors:  Sriram Bandi; Sanchit Gupta; Tatyana Tchaikovskaya; Sanjeev Gupta
Journal:  Exp Cell Res       Date:  2018-06-06       Impact factor: 3.905

Review 4.  Transcriptional Regulation of CYP2D6 Expression.

Authors:  Xian Pan; Miaoran Ning; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2016-10-03       Impact factor: 3.922

Review 5.  Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism.

Authors:  Tomas Smutny; Lucie Hyrsova; Albert Braeuning; Magnus Ingelman-Sundberg; Petr Pavek
Journal:  Arch Toxicol       Date:  2020-11-09       Impact factor: 5.153

Review 6.  Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks.

Authors:  Jean-Philippe Babeu; François Boudreau
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

7.  The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation.

Authors:  Zhongyan Wang; Peter A Burke
Journal:  Biochim Biophys Acta       Date:  2013-01-05

8.  MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation.

Authors:  Linjuan Zeng; Yinting Chen; Yong Wang; Li-Rong Yu; Bridgett Knox; Jiwei Chen; Tieliu Shi; Si Chen; Zhen Ren; Lei Guo; Yuanfeng Wu; David Liu; Kaihong Huang; Weida Tong; Dianke Yu; Baitang Ning
Journal:  Biochem Pharmacol       Date:  2017-05-26       Impact factor: 5.858

9.  Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.

Authors:  Sin-Chi Chew; Joanne Lim; Onkar Singh; Xiangai Chen; Eng-Huat Tan; Edmund-J D Lee; Balram Chowbay
Journal:  Eur J Clin Pharmacol       Date:  2013-11-06       Impact factor: 2.953

10.  Regulation of microRNA expression by rifampin in human hepatocytes.

Authors:  Anuradha Ramamoorthy; Yunlong Liu; Santosh Philips; Zeruesenay Desta; Hai Lin; Chirayu Goswami; Andrea Gaedigk; Lang Li; David A Flockhart; Todd C Skaar
Journal:  Drug Metab Dispos       Date:  2013-08-09       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.